1. Home
  2. BEAM vs DAVA Comparison

BEAM vs DAVA Comparison

Compare BEAM & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • DAVA
  • Stock Information
  • Founded
  • BEAM 2017
  • DAVA 2000
  • Country
  • BEAM United States
  • DAVA United Kingdom
  • Employees
  • BEAM N/A
  • DAVA N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • DAVA EDP Services
  • Sector
  • BEAM Health Care
  • DAVA Technology
  • Exchange
  • BEAM Nasdaq
  • DAVA Nasdaq
  • Market Cap
  • BEAM 1.9B
  • DAVA 1.8B
  • IPO Year
  • BEAM 2020
  • DAVA 2018
  • Fundamental
  • Price
  • BEAM $29.01
  • DAVA $30.34
  • Analyst Decision
  • BEAM Buy
  • DAVA Buy
  • Analyst Count
  • BEAM 10
  • DAVA 12
  • Target Price
  • BEAM $47.67
  • DAVA $40.09
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • DAVA 407.9K
  • Earning Date
  • BEAM 11-05-2024
  • DAVA 11-12-2024
  • Dividend Yield
  • BEAM N/A
  • DAVA N/A
  • EPS Growth
  • BEAM N/A
  • DAVA N/A
  • EPS
  • BEAM N/A
  • DAVA 0.16
  • Revenue
  • BEAM $349,643,000.00
  • DAVA $1,001,724,970.00
  • Revenue This Year
  • BEAM N/A
  • DAVA $10.77
  • Revenue Next Year
  • BEAM $10.82
  • DAVA $10.47
  • P/E Ratio
  • BEAM N/A
  • DAVA $189.19
  • Revenue Growth
  • BEAM 328.73
  • DAVA N/A
  • 52 Week Low
  • BEAM $20.84
  • DAVA $23.28
  • 52 Week High
  • BEAM $49.50
  • DAVA $81.06
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • DAVA 58.91
  • Support Level
  • BEAM $24.96
  • DAVA $29.87
  • Resistance Level
  • BEAM $29.53
  • DAVA $32.15
  • Average True Range (ATR)
  • BEAM 2.05
  • DAVA 1.19
  • MACD
  • BEAM -0.04
  • DAVA 0.01
  • Stochastic Oscillator
  • BEAM 67.05
  • DAVA 59.78

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About DAVA Endava plc (each representing one)

Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.

Share on Social Networks: